相关实验视频

Updated: Jan 13, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

对三阴性乳腺癌新辅助疗法的疗效进行比较:贝叶斯网络元回归分析

Yicheng Jiang¹, Jiajia Zeng¹, Jian Liu²

¹Department of Breast Surgery, Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin, China.

|January 10, 2026

概括

这项研究发现,与标准的甲环素和纳税相比,甲环素,纳税和编程细胞死亡蛋白-1 (ATPtPD1) 化疗显著改善了三阴性乳腺癌 (TNBC) 患者的病理完整反应 (pCR) 和生存结果,与标准的甲环素和纳税 (AT) 方案相比.

科学领域:

在瘤学瘤学.
医学研究医学研究
临床试验临床试验

背景情况:

三阴性乳腺癌 (TNBC) 由于其侵袭性质和有限的治疗策略,提出了重大的临床挑战.
目前用于TNBC的新辅助化疗方案缺乏全面的比较疗效数据.

研究的目的:

系统地评估和比较TNBC不同新辅助化疗方案的疗效.
根据病理完整反应 (pCR) 和生存终点确定最佳的新辅助治疗策略.

主要方法:

在多个数据库 (PubMed,Embase等) 的系统文献搜索. 和临床试验登记册一直持续到2025年1月.
评估TNBC新辅助化疗的随机对照试验 (RCT) 使用贝叶斯网络元分析进行了分析.
主要终点:PCR率. 二级终点:无事件生存率 (EFS) 和总生存率 (OS) 在不同的时间点.

主要成果:

包括环素,纳税素,和编程细胞死亡蛋白-1 (ATPtPD1) 在内的疗法,与单独使用环素和纳税素 (AT) 相比,显示出明显更高的pCR率 (OR = 5.68).
与多个时间点的ATTPD1疗法相比,ATPtPD1疗法也显著改善了EFS和OS.
贝叶斯元分析证实了ATPtPD1的优越疗效,在元回归后,EFS (HR = 2.29) 和OS (HR = 2.70) 的危险比率都有显著的优势.

结论:

甲环素,纳克桑,和编程细胞死亡蛋白-1 (ATPtPD1) 的组合疗法代表了TNBC的优质新辅助治疗选择.
应强烈考虑ATPtPD1作为三阴性乳腺癌患者推的新辅助疗法,提供改善的PCR和生存益处.

关键词:

贝叶斯网络的元分析.化疗化疗是一种化学疗法.免疫检查点抑制剂免疫检查点抑制剂作为一种新辅助治疗,新辅助治疗.网络元回归分析.三重阴性乳腺癌是什么

更多相关视频

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...